2018 (4) TMI 935 - HC - Income Tax

TPA - comparable selection - inclusion of a comparable Modicare Limited and the exclusion of the other comparables, (which are involved in trading in similar products) - Held that - The appeal should be re-examined by the ITAT; it should be addressed on these two aspects i.e. firstly, the appropriateness of including Modicare Ltd. having regard to the availability of data with respect to the different product segments, and secondly, involving the comparable, the functional difference with respect to its marketing strategy (i.e. discount, transportation costs, insurance and performing the warranty function). Having regard to the factors mentioned the ITAT is also directed to re-examine whether and to what extent adjustment can be reasonably made, having regard to the available data in respect to the trading comparables offered for ALP determination, for all the relevant years by the assessee. It is also directed to consider the feasibility again having regard to the available data for all the concerned assessment years- marking appropriate adjustments (including with respect to the working capital adjustments as is sought to be urged by the assessee) in regard to the trading comparables offered by the assessee for these given years.

Issues Involved:
1. Inclusion of Modicare Limited as a comparable.
2. Exclusion of other comparables involved in trading similar products.
3. Appropriateness of the "Most Appropriate Method" for transfer pricing.
4. Functional dissimilarities between the assessee and Modicare Limited.
5. Adjustments for differences in marketing strategies and product segments.

Detailed Analysis:

1. Inclusion of Modicare Limited as a Comparable:
The primary issue was whether the ITAT erred in including Modicare Limited as a comparable for the assessee, who is involved in the distribution and sale of cosmetic products through direct selling channels. The ITAT noted significant functional differences between Modicare Limited and the assessee, particularly in terms of product range, revenue recognition policies, and the nature of their marketing strategies. Despite these differences, the ITAT did not exclude Modicare Limited altogether but directed a remand for further examination of these differences and potential adjustments.

2. Exclusion of Other Comparables:
The assessee argued that other comparables, which did not involve direct marketing but were trading entities, should have been considered with appropriate adjustments. The ITAT did not return findings on these issues, leading to the assessee's grievance. The Revenue Authorities had rejected these comparables on the grounds of differential marketing strategies and the past acceptance of such comparables not binding the Revenue.

3. Appropriateness of the "Most Appropriate Method":
The Revenue's counsel relied on Rule 10B of the Income Tax Rules, 1962, arguing that the appropriateness of the "Most Appropriate Method" could be argued by the assessee upon remand. The ITAT was directed to re-examine whether the Transactional Net Margin Method (TNMM) is more appropriate than the Resale Price Method (RPM), considering the available data for all relevant assessment years.

4. Functional Dissimilarities:
The ITAT acknowledged the significant functional dissimilarities between Modicare Limited and the assessee, such as the different product lines and the proportion of turnover attributable to each product. The Tribunal noted that Modicare Limited's involvement in various product segments like laundry, home care, personal care, agriculture, tea, jewelry, cosmetics, and healthcare impacted its profitability differently compared to the assessee, who solely marketed cosmetics. Despite recognizing these differences, the ITAT did not exclude Modicare Limited but suggested adjustments.

5. Adjustments for Marketing Strategies and Product Segments:
The ITAT directed the Transfer Pricing Officer (TPO) to consider necessary adjustments for differences in marketing strategies, such as discounts, transportation costs, insurance, and warranty functions. The Tribunal emphasized the need for comparables engaged primarily in direct sales with no significant value addition activities. The ITAT was also directed to re-examine the feasibility of adjustments for trading comparables offered by the assessee, including working capital adjustments.

Conclusion:
The High Court found that the ITAT's decision to include Modicare Limited as a comparable, despite significant functional dissimilarities, was a vital infirmity needing correction. The Court directed the ITAT to re-examine the appropriateness of including Modicare Limited and the feasibility of adjustments for trading comparables. The ITAT was also tasked with considering the appropriateness of the TNMM over the RPM. The appeal was allowed, and the parties were directed to be present before the ITAT on a specified date for further proceedings.

← Previous Next →